Complicated Pneumonia (CP) in Children in South-East Europe (NCT06657898) | Clinical Trial Compass
RecruitingNot Applicable
Complicated Pneumonia (CP) in Children in South-East Europe
Serbia300 participantsStarted 2024-05-27
Plain-language summary
This retrospective observational study aims to evaluate clinical course of complicated community acquired pneumonia in children, particularly focusing on necrotizing pneumonia cases, as well as determination of etiological agents (viruses and bacteria) and its association to severity and outcomes of the disease. Furthermore, therapeutic approach, complications, short-term and long-term outcomes and the prevention of the disease are to be assessed. The study will encompass data from pediatric centers in the South-East Europe willing to participate in the study, encompassing ten-year period of time.
Who can participate
Age range
1 Month – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Children aged 1 month to 18 years of age
* Children diagnosed with complicated community acquired pneumonia (pneumonia with parapneumonic effusion, necrotizing pneumonia and lung abscess)
* Children who were hospitalized from January 1st 2014 to April 30th 2024 and required at least 24 hours of hospital stay
Exclusion Criteria
* Children with increased risk for severe lung infections (cystic fibrosis, primary ciliary dyskinesia, immunodeficiencies, congenital lung abnormalities, neurological conditions, chemotherapy)
* Children with hospital-acquired pneumonia
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this study is specifically tracking necrotizing pneumonia, lung abscess, and pleural empyema in children across South-East Europe, would my child's diagnosis fit the type of complicated pneumonia they're collecting data on?
2This appears to be an observational study that's counting and tracking cases rather than testing a new treatment — does that mean participating wouldn't change my child's current treatment plan, and what would actually be expected of us if we enrolled?
3Since this trial is focused on understanding how common these severe complications are, would any information gathered through this study directly benefit my child's care right now, or is it mainly helping future patients?
4Given that this study involves children with serious complications like necrotizing pneumonia and empyema, are there any extra tests, procedures, or hospital visits beyond what my child would normally need for treatment?
5Are there standard-of-care treatment approaches for complicated pneumonia that my child should be receiving regardless of this study, and would you recommend focusing on those first before considering participation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of children hospitalized and diagnosed with complicated (particularly necrotizing) community-acquired pneumonia relative to the total number of children hospitalized for community-acquired pneumonia over the study period and for each year